Cargando…

Use of the viral 2A peptide for bicistronic expression in transgenic mice

BACKGROUND: Transgenic animals are widely used in biomedical research and biotechnology. Multicistronic constructs, in which several proteins are encoded by a single messenger RNA, are commonly used in genetically engineered animals. This is currently done by using an internal ribosomal entry site t...

Descripción completa

Detalles Bibliográficos
Autores principales: Trichas, Georgios, Begbie, Jo, Srinivas, Shankar
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553761/
https://www.ncbi.nlm.nih.gov/pubmed/18793381
http://dx.doi.org/10.1186/1741-7007-6-40
_version_ 1782159524524720128
author Trichas, Georgios
Begbie, Jo
Srinivas, Shankar
author_facet Trichas, Georgios
Begbie, Jo
Srinivas, Shankar
author_sort Trichas, Georgios
collection PubMed
description BACKGROUND: Transgenic animals are widely used in biomedical research and biotechnology. Multicistronic constructs, in which several proteins are encoded by a single messenger RNA, are commonly used in genetically engineered animals. This is currently done by using an internal ribosomal entry site to separate the different coding regions. 2A peptides result in the co-translational 'cleavage' of proteins and are an attractive alternative to the internal ribosomal entry site. They are more reliable than the internal ribosomal entry site and lead to expression of multiple cistrons at equimolar levels. They work in a wide variety of eukaryotic cells, but to date have not been demonstrated to function in transgenic mice in an inheritable manner. RESULTS: To test 2A function in transgenic mice and uncover any possible toxicity of widespread expression of the 2A peptide, we made a bicistronic reporter construct containing the coding sequence for a membrane localised red fluorescent protein (Myr-TdTomato) and a nuclear localised green fluorescent protein (H2B-GFP), separated by a 2A sequence. When this reporter is transfected into HeLa cells, the two fluorescent proteins correctly localise to mutually exclusive cellular compartments, demonstrating that the bicistronic construct is a reliable readout of 2A function. The two fluorescent proteins also correctly localise when the reporter is electroporated into chick neural tube cells. We made two independent transgenic mouse lines that express the bicistronic reporter ubiquitously. For both lines, transgenic mice are born in Mendelian frequencies and are found to be healthy and fertile. Myr-TdTomato and H2B-GFP segregate to mutually exclusive cellular compartments in all tissues examined from a broad range of developmental stages, ranging from embryo to adult. One transgenic line shows X-linked inheritance of the transgene and mosaic expression in females but uniform expression in males, indicating that the transgene has integrated into the X chromosome in this line. CONCLUSION: The 2A peptide efficiently mediates co-translational cleavage in transgenic mice in which it has been inherited through the germ-line. Mice expressing it ubiquitously throughout development and into adulthood appear normal. It is therefore a viable tool for use in genetically engineered mice and represents a superior alternative to the widely used internal ribosomal entry site.
format Text
id pubmed-2553761
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25537612008-09-27 Use of the viral 2A peptide for bicistronic expression in transgenic mice Trichas, Georgios Begbie, Jo Srinivas, Shankar BMC Biol Methodology Article BACKGROUND: Transgenic animals are widely used in biomedical research and biotechnology. Multicistronic constructs, in which several proteins are encoded by a single messenger RNA, are commonly used in genetically engineered animals. This is currently done by using an internal ribosomal entry site to separate the different coding regions. 2A peptides result in the co-translational 'cleavage' of proteins and are an attractive alternative to the internal ribosomal entry site. They are more reliable than the internal ribosomal entry site and lead to expression of multiple cistrons at equimolar levels. They work in a wide variety of eukaryotic cells, but to date have not been demonstrated to function in transgenic mice in an inheritable manner. RESULTS: To test 2A function in transgenic mice and uncover any possible toxicity of widespread expression of the 2A peptide, we made a bicistronic reporter construct containing the coding sequence for a membrane localised red fluorescent protein (Myr-TdTomato) and a nuclear localised green fluorescent protein (H2B-GFP), separated by a 2A sequence. When this reporter is transfected into HeLa cells, the two fluorescent proteins correctly localise to mutually exclusive cellular compartments, demonstrating that the bicistronic construct is a reliable readout of 2A function. The two fluorescent proteins also correctly localise when the reporter is electroporated into chick neural tube cells. We made two independent transgenic mouse lines that express the bicistronic reporter ubiquitously. For both lines, transgenic mice are born in Mendelian frequencies and are found to be healthy and fertile. Myr-TdTomato and H2B-GFP segregate to mutually exclusive cellular compartments in all tissues examined from a broad range of developmental stages, ranging from embryo to adult. One transgenic line shows X-linked inheritance of the transgene and mosaic expression in females but uniform expression in males, indicating that the transgene has integrated into the X chromosome in this line. CONCLUSION: The 2A peptide efficiently mediates co-translational cleavage in transgenic mice in which it has been inherited through the germ-line. Mice expressing it ubiquitously throughout development and into adulthood appear normal. It is therefore a viable tool for use in genetically engineered mice and represents a superior alternative to the widely used internal ribosomal entry site. BioMed Central 2008-09-15 /pmc/articles/PMC2553761/ /pubmed/18793381 http://dx.doi.org/10.1186/1741-7007-6-40 Text en Copyright © 2008 Trichas et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Trichas, Georgios
Begbie, Jo
Srinivas, Shankar
Use of the viral 2A peptide for bicistronic expression in transgenic mice
title Use of the viral 2A peptide for bicistronic expression in transgenic mice
title_full Use of the viral 2A peptide for bicistronic expression in transgenic mice
title_fullStr Use of the viral 2A peptide for bicistronic expression in transgenic mice
title_full_unstemmed Use of the viral 2A peptide for bicistronic expression in transgenic mice
title_short Use of the viral 2A peptide for bicistronic expression in transgenic mice
title_sort use of the viral 2a peptide for bicistronic expression in transgenic mice
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553761/
https://www.ncbi.nlm.nih.gov/pubmed/18793381
http://dx.doi.org/10.1186/1741-7007-6-40
work_keys_str_mv AT trichasgeorgios useoftheviral2apeptideforbicistronicexpressionintransgenicmice
AT begbiejo useoftheviral2apeptideforbicistronicexpressionintransgenicmice
AT srinivasshankar useoftheviral2apeptideforbicistronicexpressionintransgenicmice